歯周病治療の世界市場見通し2017-2023

【英語タイトル】Periodontal Therapeutics - Global Market Outlook (2017-2023)

Stratistics MRCが出版した調査資料(SMRC7091163)・商品コード:SMRC7091163
・発行会社(調査会社):Stratistics MRC
・発行日:2017年8月
・ページ数:158
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:産業未分類
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥468,950見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥593,250見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥847,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、歯周病治療の世界市場について調査・分析し、歯周病治療の世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
- エグゼクティブサマリー
- 序文
- 歯周病治療の世界市場:市場動向分析
- 歯周病治療の世界市場:競争要因分析
- 歯周病治療の世界市場:製品別
・局所抗生物質
・抗生物質の全身投与
- 歯周病治療の世界市場:流通経路別
・小売薬局
・eコマース
・ドラッグストア
・病院薬局
- 歯周病治療の世界市場:主要地域別分析
- 歯周病治療の北米市場規模(アメリカ市場等)
- 歯周病治療のヨーロッパ市場規模
- 歯周病治療のアジア市場規模(日本市場、中国市場、インド市場等)
・歯周病治療の世界市場:主な市場開拓
- 関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Periodontal Therapeutics Market is valued at $259.34 million in 2016 and is expected to reach $511.76 million by 2023 growing at a CAGR of 10.2% from 2016 to 2023. Owing to increasing pool of diabetic patients will raise the Periodontal Therapeutics market growth. In addition, rising prevalence of periodontal disorders and the surging research activities for technological advancements in therapeutics are some factors positively impacting the growth. On the other hand, lack of favourable reimbursement policies in various countries across the world may limit the growth of this market.

By product, systemic antibiotics segment have the largest market share and is expected to remain the same for next few years due to high market penetration by product affordability. Followed by local antibiotics segment expected to grow faster due less chances of formation of resistant bacteria following fewer side effects. North American region has the largest market share in periodontal therapeutics market by increasing healthcare expenditure leading to increased demand for better oral healthcare therapeutics. Asia Pacific region is expected to grow at a higher CAGR during the forecast period owing to its population growth.

Some of the key players in the market include Fibrocell Sciences, Inc, Tolmar Inc, Eli Lilly & Company, Align Technology Inc., Dentsply International, 3M-ESPE, Ultradent Products Inc., Nobel Biocare Holdings AG, Glidewell Laboratories, Inc., Orapharma, Kaken Pharmaceutical, Valeant Pharmaceuticals Int. Inc, Den-Mat Holdings, Mallinckrodt Pharmaceuticals, Purdue Pharma L.P., Teva Pharmaceutical Industries Limited .

Product Type Covered:
• Local Antibiotics
o Arestin
o Other Local Antibiotics
• Systemic Antibiotics
o Minocycline
o Metronidazole
o Doxycycline
o Other Systemic Antibiotics


Distribution Channel Covered:
• Retail Pharmacies
• E-Commerce
• Drug Stores
• Hospitals Pharmacies

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o U.K
o France
o Italy
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa
What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Emerging Markets
3.8 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Periodontal Therapeutics Market, By Product
5.1 Introduction
5.2 Local Antibiotics
5.2.1 Arestin
5.2.2 Other Local Antibiotics
5.3 Systemic Antibiotics
5.3.1 Minocycline
5.3.2 Metronidazole
5.3.3 Doxycycline
5.3.4 Other Systemic Antibiotics

6 Global Periodontal Therapeutics Market, By Distribution Channel
6.1 Introduction
6.2 Retail Pharmacies
6.3 E-Commerce
6.4 Drug Stores
6.5 Hospitals Pharmacies

7 Global Periodontal Therapeutics Market, By Geography
7.1 Introduction
7.2 North America
7.2.1 US
7.2.2 Canada
7.2.3 Mexico
7.3 Europe
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Italy
7.3.5 Spain
7.3.6 Rest of Europe
7.3 Asia Pacific
7.3.1 Japan
7.3.2 China
7.3.3 India
7.3.4 Australia
7.3.5 New Zealand
7.3.6 South Korea
7.3.7 Rest of Asia Pacific
7.4 South America
7.4.1 Argentina
7.4.2 Brazil
7.4.3 Chile
7.4.4 Rest of Middle East & Africa
7.5 Middle East & Africa
7.5.1 Saudi Arabia
7.5.2 UAE
7.5.3 Qatar
7.5.4 South Africa
7.5.5 Rest of Middle East & Africa

8 Key Developments
8.1 Agreements, Partnerships, Collaborations and Joint Ventures
8.2 Acquisitions & Mergers
8.3 New Product Launch
8.4 Expansions
8.5 Other Key Strategies

9 Company Profiling
9.1 Fibrocell Sciences, Inc
9.2 Tolmar Inc
9.3 Eli Lilly & Company
9.4 Align Technology Inc.
9.5 Dentsply International
9.6 3M-ESPE
9.7 Ultradent Products Inc.
9.8 Nobel Biocare Holdings AG
9.9 Glidewell Laboratories, Inc.
9.10 Orapharma
9.11 Kaken Pharmaceutical
9.12 Valeant Pharmaceuticals Int. Inc
9.13 Den-Mat Holdings
9.14 Mallinckrodt Pharmaceuticals
9.15 Purdue Pharma L.P.
9.16 Teva Pharmaceutical Industries Limited

List of Tables
Table 1 Global Periodontal Therapeutics Market Outlook, By Region (2014-2023) ($MN)
Table 2 Global Periodontal Therapeutics Market Outlook, By Product (2014-2023) ($MN)
Table 3 Global Periodontal Therapeutics Market Outlook, By Local Antibiotics (2014-2023) ($MN)
Table 4 Global Periodontal Therapeutics Market Outlook, By Arestin (2014-2023) ($MN)
Table 5 Global Periodontal Therapeutics Market Outlook, By Other Local Antibiotics (2014-2023) ($MN)
Table 6 Global Periodontal Therapeutics Market Outlook, By Systemic Antibiotics (2014-2023) ($MN)
Table 7 Global Periodontal Therapeutics Market Outlook, By Minocycline (2014-2023) ($MN)
Table 8 Global Periodontal Therapeutics Market Outlook, By Metronidazole (2014-2023) ($MN)
Table 9 Global Periodontal Therapeutics Market Outlook, By Doxycycline (2014-2023) ($MN)
Table 10 Global Periodontal Therapeutics Market Outlook, By Other Systemic Antibiotics (2014-2023) ($MN)
Table 11 Global Periodontal Therapeutics Market Outlook, By Distribution Channel (2014-2023) ($MN)
Table 12 Global Periodontal Therapeutics Market Outlook, By Retail Pharmacies (2014-2023) ($MN)
Table 13 Global Periodontal Therapeutics Market Outlook, By E-Commerce (2014-2023) ($MN)
Table 14 Global Periodontal Therapeutics Market Outlook, By Drug Stores (2014-2023) ($MN)
Table 15 Global Periodontal Therapeutics Market Outlook, By Hospitals Pharmacies (2014-2023) ($MN)
Table 16 North America Periodontal Therapeutics Market Outlook, By Country (2014-2023) ($MN)
Table 17 North America Periodontal Therapeutics Market Outlook, By Product (2014-2023) ($MN)
Table 18 North America Periodontal Therapeutics Market Outlook, By Local Antibiotics (2014-2023) ($MN)
Table 19 North America Periodontal Therapeutics Market Outlook, By Arestin (2014-2023) ($MN)
Table 20 North America Periodontal Therapeutics Market Outlook, By Other Local Antibiotics (2014-2023) ($MN)
Table 21 North America Periodontal Therapeutics Market Outlook, By Systemic Antibiotics (2014-2023) ($MN)
Table 22 North America Periodontal Therapeutics Market Outlook, By Minocycline (2014-2023) ($MN)
Table 23 North America Periodontal Therapeutics Market Outlook, By Metronidazole (2014-2023) ($MN)
Table 24 North America Periodontal Therapeutics Market Outlook, By Doxycycline (2014-2023) ($MN)
Table 25 North America Periodontal Therapeutics Market Outlook, By Other Systemic Antibiotics (2014-2023) ($MN)
Table 26 North America Periodontal Therapeutics Market Outlook, By Distribution Channel (2014-2023) ($MN)
Table 27 North America Periodontal Therapeutics Market Outlook, By Retail Pharmacies (2014-2023) ($MN)
Table 28 North America Periodontal Therapeutics Market Outlook, By E-Commerce (2014-2023) ($MN)
Table 29 North America Periodontal Therapeutics Market Outlook, By Drug Stores (2014-2023) ($MN)
Table 30 North America Periodontal Therapeutics Market Outlook, By Hospitals Pharmacies (2014-2023) ($MN)
Table 31 Europe Periodontal Therapeutics Market Outlook, By Country (2014-2023) ($MN)
Table 32 Europe Periodontal Therapeutics Market Outlook, By Product (2014-2023) ($MN)
Table 33 Europe Periodontal Therapeutics Market Outlook, By Local Antibiotics (2014-2023) ($MN)
Table 34 Europe Periodontal Therapeutics Market Outlook, By Arestin (2014-2023) ($MN)
Table 35 Europe Periodontal Therapeutics Market Outlook, By Other Local Antibiotics (2014-2023) ($MN)
Table 36 Europe Periodontal Therapeutics Market Outlook, By Systemic Antibiotics (2014-2023) ($MN)
Table 37 Europe Periodontal Therapeutics Market Outlook, By Minocycline (2014-2023) ($MN)
Table 38 Europe Periodontal Therapeutics Market Outlook, By Metronidazole (2014-2023) ($MN)
Table 39 Europe Periodontal Therapeutics Market Outlook, By Doxycycline (2014-2023) ($MN)
Table 40 Europe Periodontal Therapeutics Market Outlook, By Other Systemic Antibiotics (2014-2023) ($MN)
Table 41 Europe Periodontal Therapeutics Market Outlook, By Distribution Channel (2014-2023) ($MN)
Table 42 Europe Periodontal Therapeutics Market Outlook, By Retail Pharmacies (2014-2023) ($MN)
Table 43 Europe Periodontal Therapeutics Market Outlook, By E-Commerce (2014-2023) ($MN)
Table 44 Europe Periodontal Therapeutics Market Outlook, By Drug Stores (2014-2023) ($MN)
Table 45 Europe Periodontal Therapeutics Market Outlook, By Hospitals Pharmacies (2014-2023) ($MN)
Table 46 Asia Pacific Periodontal Therapeutics Market Outlook, By Country (2014-2023) ($MN)
Table 47 Asia Pacific Periodontal Therapeutics Market Outlook, By Product (2014-2023) ($MN)
Table 48 Asia Pacific Periodontal Therapeutics Market Outlook, By Local Antibiotics (2014-2023) ($MN)
Table 49 Asia Pacific Periodontal Therapeutics Market Outlook, By Arestin (2014-2023) ($MN)
Table 50 Asia Pacific Periodontal Therapeutics Market Outlook, By Other Local Antibiotics (2014-2023) ($MN)
Table 51 Asia Pacific Periodontal Therapeutics Market Outlook, By Systemic Antibiotics (2014-2023) ($MN)
Table 52 Asia Pacific Periodontal Therapeutics Market Outlook, By Minocycline (2014-2023) ($MN)
Table 53 Asia Pacific Periodontal Therapeutics Market Outlook, By Metronidazole (2014-2023) ($MN)
Table 54 Asia Pacific Periodontal Therapeutics Market Outlook, By Doxycycline (2014-2023) ($MN)
Table 55 Asia Pacific Periodontal Therapeutics Market Outlook, By Other Systemic Antibiotics (2014-2023) ($MN)
Table 56 Asia Pacific Periodontal Therapeutics Market Outlook, By Distribution Channel (2014-2023) ($MN)
Table 57 Asia Pacific Periodontal Therapeutics Market Outlook, By Retail Pharmacies (2014-2023) ($MN)
Table 58 Asia Pacific Periodontal Therapeutics Market Outlook, By E-Commerce (2014-2023) ($MN)
Table 59 Asia Pacific Periodontal Therapeutics Market Outlook, By Drug Stores (2014-2023) ($MN)
Table 60 Asia Pacific Periodontal Therapeutics Market Outlook, By Hospitals Pharmacies (2014-2023) ($MN)
Table 61 South America Periodontal Therapeutics Market Outlook, By Country (2014-2023) ($MN)
Table 62 South America Periodontal Therapeutics Market Outlook, By Product (2014-2023) ($MN)
Table 63 South America Periodontal Therapeutics Market Outlook, By Local Antibiotics (2014-2023) ($MN)
Table 64 South America Periodontal Therapeutics Market Outlook, By Arestin (2014-2023) ($MN)
Table 65 South America Periodontal Therapeutics Market Outlook, By Other Local Antibiotics (2014-2023) ($MN)
Table 66 South America Periodontal Therapeutics Market Outlook, By Systemic Antibiotics (2014-2023) ($MN)
Table 67 South America Periodontal Therapeutics Market Outlook, By Minocycline (2014-2023) ($MN)
Table 68 South America Periodontal Therapeutics Market Outlook, By Metronidazole (2014-2023) ($MN)
Table 69 South America Periodontal Therapeutics Market Outlook, By Doxycycline (2014-2023) ($MN)
Table 70 South America Periodontal Therapeutics Market Outlook, By Other Systemic Antibiotics (2014-2023) ($MN)
Table 71 South America Periodontal Therapeutics Market Outlook, By Distribution Channel (2014-2023) ($MN)
Table 72 South America Periodontal Therapeutics Market Outlook, By Retail Pharmacies (2014-2023) ($MN)
Table 73 South America Periodontal Therapeutics Market Outlook, By E-Commerce (2014-2023) ($MN)
Table 74 South America Periodontal Therapeutics Market Outlook, By Drug Stores (2014-2023) ($MN)
Table 75 South America Periodontal Therapeutics Market Outlook, By Hospitals Pharmacies (2014-2023) ($MN)
Table 76 Middle East & Africa Periodontal Therapeutics Market Outlook, By Country (2014-2023) ($MN)
Table 77 Middle East & Africa Periodontal Therapeutics Market Outlook, By Product (2014-2023) ($MN)
Table 78 Middle East & Africa Periodontal Therapeutics Market Outlook, By Local Antibiotics (2014-2023) ($MN)
Table 79 Middle East & Africa Periodontal Therapeutics Market Outlook, By Arestin (2014-2023) ($MN)
Table 80 Middle East & Africa Periodontal Therapeutics Market Outlook, By Other Local Antibiotics (2014-2023) ($MN)
Table 81 Middle East & Africa Periodontal Therapeutics Market Outlook, By Systemic Antibiotics (2014-2023) ($MN)
Table 82 Middle East & Africa Periodontal Therapeutics Market Outlook, By Minocycline (2014-2023) ($MN)
Table 83 Middle East & Africa Periodontal Therapeutics Market Outlook, By Metronidazole (2014-2023) ($MN)
Table 84 Middle East & Africa Periodontal Therapeutics Market Outlook, By Doxycycline (2014-2023) ($MN)
Table 85 Middle East & Africa Periodontal Therapeutics Market Outlook, By Other Systemic Antibiotics (2014-2023) ($MN)
Table 86 Middle East & Africa Periodontal Therapeutics Market Outlook, By Distribution Channel (2014-2023) ($MN)
Table 87 Middle East & Africa Periodontal Therapeutics Market Outlook, By Retail Pharmacies (2014-2023) ($MN)
Table 88 Middle East & Africa Periodontal Therapeutics Market Outlook, By E-Commerce (2014-2023) ($MN)
Table 89 Middle East & Africa Periodontal Therapeutics Market Outlook, By Drug Stores (2014-2023) ($MN)
Table 90 Middle East & Africa Periodontal Therapeutics Market Outlook, By Hospitals Pharmacies (2014-2023) ($MN)



★調査レポート[歯周病治療の世界市場見通し2017-2023] (コード:SMRC7091163)販売に関する免責事項を必ずご確認ください。
★調査レポート[歯周病治療の世界市場見通し2017-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆